Bajpai P, Agarwal S, Afaq F, Al Diffalha S, Chandrashekar D, Kim H
J Exp Clin Cancer Res. 2024; 43(1):192.
PMID: 38992681
PMC: 11238352.
DOI: 10.1186/s13046-024-03106-8.
Wang X, Chan S, Dai L, Xu Y, Yang Q, Wang M
J Cancer. 2024; 15(5):1234-1254.
PMID: 38356712
PMC: 10861827.
DOI: 10.7150/jca.91835.
Zamani F, Khalighfard S, Kalhori M, Poorkhani A, Amiriani T, Hosseinzadeh P
Med Oncol. 2023; 40(10):302.
PMID: 37725175
DOI: 10.1007/s12032-023-02170-y.
Chan S, Wang X, Wang Z, Du Y, Zuo X, Chen J
Int J Biol Sci. 2023; 19(7):2220-2233.
PMID: 37151875
PMC: 10158020.
DOI: 10.7150/ijbs.82000.
Mohseni N, Ghaniee Zarich M, Afshar S, Hosseini M
J Gastrointest Cancer. 2022; 54(3):937-950.
PMID: 36534304
DOI: 10.1007/s12029-022-00873-5.
IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis.
Zhang S, Yang G
Front Immunol. 2022; 13:915246.
PMID: 35874683
PMC: 9304570.
DOI: 10.3389/fimmu.2022.915246.
circFCHO2 promotes gastric cancer progression by activating the JAK1/STAT3 pathway via sponging miR-194-5p.
Zhang Z, Sun C, Zheng Y, Gong Y
Cell Cycle. 2022; 21(20):2145-2164.
PMID: 35708677
PMC: 9519002.
DOI: 10.1080/15384101.2022.2087280.
Rutaecarpine suppresses the proliferation and metastasis of colon cancer cells by regulating the STAT3 signaling.
Chan S, Sun R, Tu X, Guo M, Yuan Q, Yu Z
J Cancer. 2022; 13(3):847-857.
PMID: 35154453
PMC: 8824880.
DOI: 10.7150/jca.66177.
Genomic landscape of colorectal carcinogenesis.
Kim J, Bodmer W
J Cancer Res Clin Oncol. 2022; 148(3):533-545.
PMID: 35048197
DOI: 10.1007/s00432-021-03888-w.
Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase the WHO Global Database of Individual Case Safety Reports.
Crosnier A, Abbara C, Cellier M, Lagarce L, Babin M, Bourneau-Martin D
Cancers (Basel). 2021; 13(23).
PMID: 34885014
PMC: 8657199.
DOI: 10.3390/cancers13235907.
Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang Y, Chen K, Tsai J, Cheng Y, Lee C, Kao C
J Biomed Sci. 2021; 28(1):75.
PMID: 34758826
PMC: 8579664.
DOI: 10.1186/s12929-021-00769-9.
Ruxolitinib induces apoptosis of human colorectal cancer cells by downregulating the JAK1/2-STAT1-Mcl-1 axis.
Li X, Wang Z, Zhang S, Yao Q, Chen W, Liu F
Oncol Lett. 2021; 21(5):352.
PMID: 33747209
PMC: 7967999.
DOI: 10.3892/ol.2021.12613.
Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling.
Bai J, Zhang X, Shi D, Xiang Z, Wang S, Yang C
Front Cell Dev Biol. 2021; 9:568738.
PMID: 33634112
PMC: 7900423.
DOI: 10.3389/fcell.2021.568738.
Targeting oncogenic mutations in colorectal cancer using cryptotanshinone.
Vundavilli H, Datta A, Sima C, Hua J, Lopes R, Bittner M
PLoS One. 2021; 16(2):e0247190.
PMID: 33596259
PMC: 7888617.
DOI: 10.1371/journal.pone.0247190.
Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.
Xu H, Liu L, Li W, Zou D, Yu J, Wang L
Oncogene. 2020; 40(9):1555-1569.
PMID: 33323976
DOI: 10.1038/s41388-020-01587-3.
Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer.
Nagaraju G, Farran B, Farren M, Chalikonda G, Wu C, Lesinski G
Cancer. 2020; 126(14):3360-3371.
PMID: 32383803
PMC: 7380507.
DOI: 10.1002/cncr.32954.
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
Zhao Y, Li Y, Sheng J, Wu F, Li K, Huang R
J Exp Clin Cancer Res. 2019; 38(1):379.
PMID: 31455383
PMC: 6712617.
DOI: 10.1186/s13046-019-1375-9.
HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway.
Chen W, Wu G, Zhu Y, Zhang W, Zhang H, Zhou Y
Cancer Manag Res. 2019; 11:6625-6635.
PMID: 31406476
PMC: 6642621.
DOI: 10.2147/CMAR.S201342.
Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway.
Cui C, Cheng X, Yan L, Ding H, Guan X, Zhang W
Cancer Manag Res. 2019; 11:6323-6341.
PMID: 31372038
PMC: 6628123.
DOI: 10.2147/CMAR.S198911.
TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling.
Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X
Cancer Cell Int. 2019; 19:57.
PMID: 30918473
PMC: 6419475.
DOI: 10.1186/s12935-019-0775-4.
